Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients

Purpose: Radiotherapy for patients with non-metastatic human epidermal growth factor receptor 2 (HER2) positive breast cancer is commonly administered concurrently with adjuvant trastuzumab. However, there is limited data on the use of concurrent trastuzumab and hypofractionated radiotherapy (Hypo-R...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayan, Mutlay, Abou Yehia, Zeinab, Gupta, Apar, Toppmeyer, Deborah, Ohri, Nisha, Haffty, Bruce G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779787/
https://www.ncbi.nlm.nih.gov/pubmed/31632906
http://dx.doi.org/10.3389/fonc.2019.00970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779787/
https://www.ncbi.nlm.nih.gov/pubmed/31632906
http://dx.doi.org/10.3389/fonc.2019.00970

Ejemplares similares